Global RNA Drugs Market Status and Outlook 2018-2025

August 2018 | 142 pages | ID: G94025EB3EAEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Pfizer
• Roche
• Sanofi-Aventis
• Abbott Laboratories
• Arrowhead Pharmaceuticals
• Benitec Biopharma
• Calimmune Inc
• Dicerna
• Gradalis
• Quark
• RXi
• Senesco
• Silence Therapeutics
• Silenseed
• Tekmira
• Alnylam Pharmaceuticals

Market by Type

• siRNA
• ASO
• miRNA
• Nucleic Acid Aptamers

Market by Application

• Cancer
• Diabetes
• Tuberculosis
• Cardiovascular Diseases
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 RNA Drugs Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 siRNA
  3.1.2 ASO
  3.1.3 miRNA
  3.1.4 Nucleic Acid Aptamers
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Cancer
  4.1.2 Diabetes
  4.1.3 Tuberculosis
  4.1.4 Cardiovascular Diseases
  4.1.5 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 siRNA Production by Region
    6.1.1.2 ASO Production by Region
    6.1.1.3 miRNA Production by Region
    6.1.1.4 Nucleic Acid Aptamers Production by Region
  6.1.2 Production by Application
    6.1.2.1 Cancer Production by Region
    6.1.2.2 Diabetes Production by Region
    6.1.2.3 Tuberculosis Production by Region
    6.1.2.4 Cardiovascular Diseases Production by Region
    6.1.2.5 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 siRNA Demand by Region
    6.2.1.2 ASO Demand by Region
    6.2.1.3 miRNA Demand by Region
    6.2.1.4 Nucleic Acid Aptamers Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Cancer Demand by Region
    6.2.2.2 Diabetes Demand by Region
    6.2.2.3 Tuberculosis Demand by Region
    6.2.2.4 Cardiovascular Diseases Demand by Region
    6.2.2.5 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Pfizer
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Roche
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Sanofi-Aventis
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Abbott Laboratories
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Arrowhead Pharmaceuticals
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Benitec Biopharma
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Calimmune Inc
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Dicerna
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Gradalis
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Quark
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 RXi
8.12 Senesco
8.13 Silence Therapeutics
8.14 Silenseed
8.15 Tekmira
8.16 Alnylam Pharmaceuticals

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table RNA Drugs Industry Dynamics & Regulations List
Table Global RNA Drugs Sales Revenue, Cost and Margin, 2015-2018E
Table Global RNA Drugs Market Status by Type 2015-2018E, in USD Million
Table Global RNA Drugs Market Status by Application 2015-2018E, in USD Million
Table Global RNA Drugs Market Status by Application 2015-2018E, in Volume
Table Global RNA Drugs Market by Region 2015-2018E, in USD Million
Table Global RNA Drugs Market Share by Region in 2018, in USD Million
Table Global RNA Drugs Market by Region 2015-2018E, in Volume
Table Global RNA Drugs Market Share by Region in 2018, in Volume
Table siRNA Production Value by Region 2015-2018E, in USD Million
Table siRNA Production Volume by Region 2015-2018E, in Volume
Table ASO Production Value by Region 2015-2018E, in USD Million
Table ASO Production Volume by Region 2015-2018E, in Volume
Table miRNA Production Value by Region 2015-2018E, in USD Million
Table miRNA Production Volume by Region 2015-2018E, in Volume
Table Nucleic Acid Aptamers Production Value by Region 2015-2018E, in USD Million
Table Nucleic Acid Aptamers Production Volume by Region 2015-2018E, in Volume
Table Cancer Production Value by Region 2015-2018E, in USD Million
Table Cancer Production Volume by Region 2015-2018E, in Volume
Table Diabetes Production Value by Region 2015-2018E, in USD Million
Table Diabetes Production Volume by Region 2015-2018E, in Volume
Table Tuberculosis Production Value by Region 2015-2018E, in USD Million
Table Tuberculosis Production Volume by Region 2015-2018E, in Volume
Table Cardiovascular Diseases Production Value by Region 2015-2018E, in USD Million
Table Cardiovascular Diseases Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table siRNA Market Size by Region 2015-2018E, in USD Million
Table siRNA Market Size by Region 2015-2018E, in Volume
Table ASO Market Size by Region 2015-2018E, in USD Million
Table ASO Market Size by Region 2015-2018E, in Volume
Table miRNA Market Size by Region 2015-2018E, in USD Million
Table miRNA Market Size by Region 2015-2018E, in Volume
Table Nucleic Acid Aptamers Market Size by Region 2015-2018E, in USD Million
Table Nucleic Acid Aptamers Market Size by Region 2015-2018E, in Volume
Table Cancer Market Size by Region 2015-2018E, in USD Million
Table Cancer Market Size by Region 2015-2018E, in Volume
Table Diabetes Market Size by Region 2015-2018E, in USD Million
Table Diabetes Market Size by Region 2015-2018E, in Volume
Table Tuberculosis Market Size by Region 2015-2018E, in USD Million
Table Tuberculosis Market Size by Region 2015-2018E, in Volume
Table Cardiovascular Diseases Market Size by Region 2015-2018E, in USD Million
Table Cardiovascular Diseases Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalRNA Drugs Forecast by Type 2019F-2025F, in USD Million
Table RNA Drugs Forecast by Type 2019F-2025F, in Volume
Table RNA Drugs Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table RNA Drugs Market Forecast by Application / End-User 2019F-2025F, in Volume
Table RNA Drugs Market Forecast by Region 2019F-2025F, in USD Million
Table RNA Drugs Market Forecast by Region 2019F-2025F, in Volume
Table Pfizer Information
Table RNA Drugs Sales, Cost, Margin of Pfizer
Table Roche Information
Table RNA Drugs Sales, Cost, Margin of Roche
Table Sanofi-Aventis Information
Table RNA Drugs Sales, Cost, Margin of Sanofi-Aventis
Table Abbott Laboratories Information
Table RNA Drugs Sales, Cost, Margin of Abbott Laboratories
Table Arrowhead Pharmaceuticals Information
Table RNA Drugs Sales, Cost, Margin of Arrowhead Pharmaceuticals
Table Benitec Biopharma Information
Table RNA Drugs Sales, Cost, Margin of Benitec Biopharma
Table Calimmune Inc Information
Table RNA Drugs Sales, Cost, Margin of Calimmune Inc
Table Dicerna Information
Table RNA Drugs Sales, Cost, Margin of Dicerna
Table Gradalis Information
Table RNA Drugs Sales, Cost, Margin of Gradalis
Table Quark Information
Table RNA Drugs Sales, Cost, Margin of Quark
Table RXi Information
Table RNA Drugs Sales, Cost, Margin of RXi
Table Senesco Information
Table RNA Drugs Sales, Cost, Margin of Senesco
Table Silence Therapeutics Information
Table RNA Drugs Sales, Cost, Margin of Silence Therapeutics
Table Silenseed Information
Table RNA Drugs Sales, Cost, Margin of Silenseed
Table Tekmira Information
Table RNA Drugs Sales, Cost, Margin of Tekmira
Table Alnylam Pharmaceuticals Information
Table RNA Drugs Sales, Cost, Margin of Alnylam Pharmaceuticals
Table Global RNA Drugs Sales Revenue by Company 2015-2017, in USD Million
Table Global RNA Drugs Sales Volume by Company 2015-2017, in Volume
Table Global RNA Drugs Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure RNA Drugs Picture
Figure RNA Drugs Industry Chain Diagram
Figure Global RNA Drugs Sales Revenue 2015-2018E, in USD Million
Figure Global RNA Drugs Sales Volume 2015-2018E, in Volume
Figure Global RNA Drugs Market Status by Type 2015-2018E, in Volume
Figure North America RNA Drugs Market Size and Growth 2015-2018E, in USD Million
Figure North America RNA Drugs Market Size and Growth 2015-2018E, in Volume
Figure Europe RNA Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Europe RNA Drugs Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific RNA Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific RNA Drugs Market Size and Growth 2015-2018E, in Volume
Figure South America RNA Drugs Market Size and Growth 2015-2018E, in USD Million
Figure South America RNA Drugs Market Size and Growth 2015-2018E, in Volume
Figure Middle East RNA Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Middle East RNA Drugs Market Size and Growth 2015-2018E, in Volume
Figure Africa RNA Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Africa RNA Drugs Market Size and Growth 2015-2018E, in Volume
Figure Global RNA Drugs Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global RNA Drugs Sales Volume Forecast 2019F-2025F, in Volume
Figure Global RNA Drugs Sales Price Forecast 2019F-2025F
Figure Global RNA Drugs Gross Margin Forecast 2019F-2025F
Figure Global RNA Drugs Sales Revenue by Company in 2018, in USD Million
Figure Global RNA Drugs Price by Company in 2018
Figure Global RNA Drugs Gross Margin by Company in 2018